Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px
Document › Details

Eurofins Scientific. (6/17/16). "Press Release: Eurofins Strengthens Its Footprint in Food and Water Testing in The Netherlands with the Acquisition of Bureau de Wit".

Region Region Almere
  Country Netherlands
Organisations Organisation Eurofins Scientific SE (EUFI.PA)
  Group Eurofins (Group)
  Organisation 2 Bureau de Wit B.V.
  Group Eurofins (Group)
Products Product food analysis (food testing)
  Product 2 water analysis
Index term Index term Bureau de Wit–Eurofins: investment, 201606 acqisition of Bureau de Wit BV by Eurofins
Person Person Martin, Gilles G. (Eurofins 200701 CEO + founder)
     


Eurofins Scientific (EUFI.PA), a world leader in bioanalytical testing supporting the entire food production chain, announces the acquisition of Bureau de Wit B.V. (“Bureau de Wit”), one of the main laboratory service providers focused on food and water safety testing for the food production, hotel and catering sectors in The Netherlands.

Bureau de Wit operates a strategically-located laboratory in Almere, and employs 64 staff, generating annual revenues in excess of EUR 5m. The company provides food and water safety and hygiene testing, with a strong reputation in the hotel and catering sectors due to its innovative, client-friendly tools and state-of-the-art client portals. Bureau de Wit’s existing competencies are entirely complementary to Eurofins’ portfolio of services, which should result in substantial cross-selling opportunities. Furthermore, its laboratory’s central location provides a perfect fit with Eurofins’ existing geographic footprint in the country.

This acquisition further reinforces Eurofins’ leadership in the Dutch food testing market and broadens its client base. In return, Bureau de Wit will benefit from Eurofins’ industry-leading laboratory network, including access to the Group’s comprehensive analytical portfolio, as well as logistical infrastructure. The existing Management of Bureau de Wit remains in place and will continue to work on the growth of the Bureau de Wit business, now as part of the successful Eurofins organisation.

Comment from Dr. Gilles Martin, Eurofins CEO: "This transaction further consolidates our leading footprint to support the food industry in The Netherlands. We look forward to giving Bureau de Wit’s clients access to the capabilities of the Eurofins network to support them in strengthening their quality and safety programs.”


For more information about Eurofins, please visit www.eurofins.com or contact:

Investor Relations
Eurofins Scientific Group
Phone: +32 2 766 1620
E-mail: ir@eurofins.com


Notes for the editor:


Eurofins – a global leader in bio-analysis

Eurofins Scientific believes it is the world leader in food, environment and pharmaceutical products testing, as well as one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

With over 23,000 staff in more than 225 laboratories across 39 countries, Eurofins offers a portfolio of over 130,000 validated analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients’ increasingly stringent quality and safety standards and the expanding demands of regulatory authorities and healthcare practitioners around the world.

The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

   
Record changed: 2016-07-01

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Eurofins (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px